[1]
2025. Palbociclib plus endocrine therapy in Premenopausal women in HR+/Her2- Breast Cancer with Visceral Metastases versus Combined Chemotherapy. Journal of Carcinogenesis. 24, 3 (Sep. 2025), 635–642. DOI:https://doi.org/10.64149/J.Carcinog.24.3.635-642.